search
Back to results

Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector (SECCI)

Primary Purpose

Liver Cirrhosis, Liver Neoplasms, Carcinoma, Hepatocellular

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
clamp crushing technique
ultrasonic dissector
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Liver Cirrhosis focused on measuring Liver cirrhosis, Hepatectomy, Liver parenchyma transection, Randomized controlled trial

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Child A liver cirrhosis
  • Partial hepatectomy (≥ 1 segment).
  • Patient at least 18 years of age

Exclusion Criteria:

  • Non cirrhotic patient
  • Child B or C cirrhosis
  • Portal hypertension
  • Laparoscopic hepatectomy.

Sites / Locations

  • Hôpital BEAUJON

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

1

2

Arm Description

Liver transection by clamp crushing technique

Liver transection by the ultrasonic dissector

Outcomes

Primary Outcome Measures

Intra-operative blood loss during liver transection (ml).

Secondary Outcome Measures

Intra-operative blood loss standardized to the transection area (ml/cm²)
free margins around the tumor
postoperative liver ischemia-reperfusion injury (post-operative peak of transaminases)
60-day postoperative complications

Full Information

First Posted
September 30, 2008
Last Updated
February 26, 2014
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00763776
Brief Title
Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector
Acronym
SECCI
Official Title
Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector : Randomized Comparative Study.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2011
Overall Recruitment Status
Terminated
Why Stopped
difficulty for the patient recruiting
Study Start Date
July 2008 (undefined)
Primary Completion Date
August 2010 (Actual)
Study Completion Date
September 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To identify the most efficient parenchyma transection technique for cirrhotic liver resection between the clamp crushing technique and the ultrasonic dissector. Primary endpoint is intra-operative blood loss during liver transection (ml). Expected results and implications: If one of the technique is better than the other, surgical teams could prefer it to minimize the morbidity of liver resection in cirrhotic patients.
Detailed Description
Design Multicentric randomized controlled simple blinded trial comparing the clamp crushing technique vs. the ultrasonic dissector. The trial will last 24 months with 21 month-inclusion time. Patients Patients will be enrolled in 5 university hospitals in Ile de France. Eligibility criteria include adults with Child A liver cirrhosis undergoing partial hepatectomy (≥ 1 liver segment). Exclusion criteria include non cirrhotic patients, Child B or C cirrhosis, portal hypertension and laparoscopic hepatectomy. Sample size calculation was performed with the expectation of a 250 ml (one red cells pack) difference in blood loss during parenchyma transection with a level of statistical significance of 0.05 and a power of 0.80. These calculations indicated to include at least 60 patients in each group. Secondary endpoints include blood loss standardized to the transection area (ml/cm²), free margins around the tumor, postoperative liver ischemia-reperfusion injury and postoperative complications. Course of the study An informed consent will be obtained from each patient prior to surgery. Each patient will be randomized the day prior to surgery. As usual, each patient will be followed daily until he will discharge (10 days) and for 2 months at the postoperative outcome patient clinic, which will end the study period for the patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Cirrhosis, Liver Neoplasms, Carcinoma, Hepatocellular
Keywords
Liver cirrhosis, Hepatectomy, Liver parenchyma transection, Randomized controlled trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
27 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Other
Arm Description
Liver transection by clamp crushing technique
Arm Title
2
Arm Type
Other
Arm Description
Liver transection by the ultrasonic dissector
Intervention Type
Device
Intervention Name(s)
clamp crushing technique
Intervention Description
Liver transection during hepatectomy by clamp crushing technique
Intervention Type
Device
Intervention Name(s)
ultrasonic dissector
Intervention Description
Liver transection during hepatectomy by the ultrasonic dissector
Primary Outcome Measure Information:
Title
Intra-operative blood loss during liver transection (ml).
Time Frame
during liver transection
Secondary Outcome Measure Information:
Title
Intra-operative blood loss standardized to the transection area (ml/cm²)
Time Frame
during liver transection
Title
free margins around the tumor
Time Frame
during liver transection
Title
postoperative liver ischemia-reperfusion injury (post-operative peak of transaminases)
Time Frame
daily until the discharge of the patient
Title
60-day postoperative complications
Time Frame
2 months after the liver transection

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Child A liver cirrhosis Partial hepatectomy (≥ 1 segment). Patient at least 18 years of age Exclusion Criteria: Non cirrhotic patient Child B or C cirrhosis Portal hypertension Laparoscopic hepatectomy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mickael LESURTEL, MD-PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital BEAUJON
City
Clichy
ZIP/Postal Code
92 118
Country
France

12. IPD Sharing Statement

Learn more about this trial

Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector

We'll reach out to this number within 24 hrs